Oncology Institute Secures $75M Term Loan, Refinances Debt, Issues Warrants
TOI has more than doubled off its 52-week low of $2.32.
Summary
Oncology Institute refinanced $86 million in convertible notes with a new $75 million term loan and issued warrants, extending debt maturity to 2031 and improving liquidity without immediate equity dilution.
Key Events · Financing and Capital Events · TOI
-
Secured New Term Loan
The company entered into a new Credit Agreement for a $75 million term loan facility from OrbiMed Opportunities (CA) V LLC, drawn in full on July 1, 2026.
-
Debt Refinancing and Maturity Extension
Proceeds from the new loan, combined with approximately $11 million cash on hand, were used to repay the outstanding $86 million 4% senior secured convertible notes due 2027. This extends the debt maturity to July 1, 2031.
-
Warrant Issuance
As part of the convertible note repayment, the company issued warrants to Deerfield Partners, L.P. to purchase 10,025,535 shares of common stock at an exercise price of $8.567 per share, expiring August 9, 2027. No additional consideration was paid for the warrants.
-
New Debt Terms and Covenants
The new term loan bears interest at a monthly rate equal to the higher of the one-month term SOFR rate or 3.00%, plus 5.75%. It is secured by a first-priority security interest in substantially all assets and includes a minimum net revenue covenant of $700 million annually, commencing December 31, 2027.
Analysis · TOI · Industrial Applications And Services
Oncology Institute has completed a strategic debt refinancing, replacing its $86 million convertible notes due 2027 with a new $75 million term loan maturing in 2031. This significantly extends the company's debt maturity profile and enhances liquidity, providing a longer financial runway. While the new loan carries a higher interest rate and includes warrants representing substantial potential future dilution, the warrants are currently out-of-the-money, and the company avoided an immediate equity raise. The transaction strengthens the balance sheet for future growth, but introduces new revenue covenants and a higher cost of debt.
At the time of this filing, TOI was trading at $5.80 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $579.9M. The 52-week trading range was $2.32 to $5.82. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.